Exacerbation of mycobacterium tuberculosis enteritis masquerading as crohn’s disease after treatment with a tumor necrosis factor-α inhibitor

This publication has 12 references indexed in Scilit:

• Effects of Tumor Necrosis Factor Alpha on Host Immune Response in Chronic Persistent Tuberculosis: Possible Role for Limiting Pathology
  Infection and Immunity, 2001
• Antimicrobial activity of MHC class I-restricted CD8+ T cells in human tuberculosis
  Proceedings of the National Academy of Sciences, 2000
• Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial
  The Lancet, 1999
• Increased exhaled nitric oxide in active pulmonary tuberculosis due to inducible NO synthase upregulation in alveolar macrophages
  European Respiratory Journal, 1998
• Tumor necrosis factor alpha (TNFalpha) promotes growth of virulent Mycobacterium tuberculosis in human monocytes iron-mediated growth suppression is correlated with decreased release of TNFalpha from iron-treated infected monocytes.
  Journal of Clinical Investigation, 1997
• Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis.
  The Journal of Experimental Medicine, 1996
• Tumor necrosis factor-α is required in the protective immune response against mycobacterium tuberculosis in mice
  Immunity, 1995
• Enhancement Of Intracellular Growth Of Mycobacterium Tuberculosis In Human Monocytes by Transforming Growth Factor- l
  The Journal of Infectious Diseases, 1994
• Mechanisms involved in mycobacterial growth inhibition by gamma interferon-activated bone marrow macrophages: role of reactive nitrogen intermediates
  Infection and Immunity, 1991
• The Role of Colonoscopy in the Diagnosis of Tuberculosis
  Journal of Clinical Gastroenterology, 1988